ChemicalBook--->CAS DataBase List--->2360523-76-6

2360523-76-6

Request For Quotation
2360523-76-6 Structure

2360523-76-6 Structure
IdentificationBack Directory
[Name]

Benzamide, N-[(3S,4S)-4-(3,4-difluorophenyl)-3-piperidinyl]-2-fluoro-4-(1-methyl-1H-pyrazol-5-yl)-, hydrochloride (1:1)
[CAS]

2360523-76-6
[Synonyms]

Hu7691
Benzamide, N-[(3S,4S)-4-(3,4-difluorophenyl)-3-piperidinyl]-2-fluoro-4-(1-methyl-1H-pyrazol-5-yl)-, hydrochloride (1:1)
[Molecular Formula]

C22H22ClF3N4O
[MOL File]

2360523-76-6.mol
[Molecular Weight]

450.89
Chemical PropertiesBack Directory
[form ]

Solid
[color ]

White to off-white
Hazard InformationBack Directory
[Uses]

Hu7691 is an orally active, selective Akt inhibitor with IC50s of 4.0 nM, 97.5 nM, 28 nM for Akt1, Akt2 and Akt3, respectively. Hu7691 inhibits tumor growth and enables decrease of cutaneous toxicity in mice[1].
[in vivo]

Hu7691 (12.5-50 mg/kg/day; i.g.; for 22 days) shows dose-dependent tumor growth inhibition[1].
Hu7691 (15 mg/kg; oral) has a T1/2 of 8.68 hours, a Cmax of 171.17 ng/mL and an AUC of 2820.64 ng/mL h in rats[1].
Hu7691 (2 mg/kg; iv) has a T1/2 of 6.24 hours, a Cmax of 207.52 ng/mL and an AUC of 532.87 ng/mL h in rats[1].
Hu7691 (20 mg/kg; oral) has a T1/2 of 16.7 hours, a Cmax of 905.65 ng/mL and an AUC of 36303 ng/mL h in beagle dog (male, 40 weeks old, 8-10 kg)[1].

Animal Model:Balb/c mice (nu/nu, female, 3-4 weeks old, 20-25 g) with 786-O and KHOS xenograft[1]
Dosage:12.5, 25, 50 mg/kg
Administration:Oral; once daily for 22 days
Result:Showed dose-dependent tumor growth inhibition.
Animal Model:SD rats (male, 8 weeks old, 250-300 g)[1]
Dosage:15 mg/kg (Pharmacokinetic Analysis)
Administration:Oral
Result:Had a T1/2 of 8.68 hours, a Cmax of 171.17 ng/mL and an AUC of 2820.64 ng/mL?h.
[IC 50]

Akt1: 4.0 nM (IC50); Akt2: 97.5 nM (IC50); Akt3: 28 nM (IC50); PKA: 11 nM (IC50); PKCη: 629 nM (IC50); ROCK1: 354 nM (IC50); RSK1: 756 nM (IC50); p70S6K: 229 nM (IC50)
[References]

[1] Jinxin Che, et al. Discovery of N-((3 S,4 S)-4-(3,4-Difluorophenyl)piperidin-3-yl)-2-fluoro-4-(1-methyl-1 H-pyrazol-5-yl)benzamide (Hu7691), a Potent and Selective Akt Inhibitor That Enables Decrease of Cutaneous Toxicity. J Med Chem. 2021 Aug 26;64(16):12163-12180. DOI:10.1021/acs.jmedchem.1c00815
Spectrum DetailBack Directory
[Spectrum Detail]

Benzamide, N-[(3S,4S)-4-(3,4-difluorophenyl)-3-piperidinyl]-2-fluoro-4-(1-methyl-1H-pyrazol-5-yl)-, hydrochloride (1:1)(2360523-76-6)1HNMR
2360523-76-6 suppliers list
Company Name: BOC Sciences  
Tel: 1-631-485-4226; 16314854226
Website: https://www.bocsci.com
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Website: https://www.targetmol.cn/
Company Name: Shenzhen Zuoke Biotechnology Co., Ltd.  
Tel: 13532174601
Website: www.chemicalbook.com/ShowSupplierProductsList1018526/0_EN.htm
Tags:2360523-76-6 Related Product Information
2360523-76-6 2241232-43-7 448947-81-7 146986-50-7